BridgeBio Pharma Inc (NASDAQ:BBIO)
| 11.81 Delayed Data As of Feb 07 |  +0.37 / +3.23%Today’s Change | 4.98 Today|||52-Week Range 12.64 | +54.99% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Kumar Neil /bridgebio/ President & Chief Executive Officer |  Sale | 1/05/2023 | 120,000 | $7.67 | $920.4K | +53.78% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 1/05/2023 | 61,040 | $7.67 | $468.2K | +53.78% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 11/16/2022 | 34,066 | $9.64 | $328.4K | +22.51% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 11/17/2022 | 34,640 | $9.40 | $325.6K | +22.38% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 11/17/2022 | 19,678 | $9.40 | $185.0K | +22.38% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 5/16/2022 | 23,759 | $6.74 | $160.1K | +75.22% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 11/16/2022 | 10,789 | $9.64 | $104.0K | +22.51% |
Ellis Andrea Director |  Buy | 3/15/2022 | 12,000 | $8.39 | $100.7K | +38.78% |
Dachille Douglas Adam Director | Buy | 3/14/2022 | 10,000 | $8.19 | $81.9K | +43.15% |
Stephenson Brian C Corporate Officer | Sale | 5/16/2022 | 9,228 | $6.74 | $62.2K | +75.22% |
Page of 3